- Home
- BYSI vs ICCM Comparison
BYSI vs ICCM Comparison
Compare BYSI & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYSI
- ICCM
- Stock Information
- Founded
- BYSI 2010
- ICCM 2006
- Country
- BYSI United States
- ICCM Israel
- Employees
- BYSI N/A
- ICCM N/A
- Industry
- BYSI Biotechnology: Pharmaceutical Preparations
- ICCM
- Sector
- BYSI Health Care
- ICCM
- Exchange
- BYSI Nasdaq
- ICCM Nasdaq
- Market Cap
- BYSI 72.1M
- ICCM 70.1M
- IPO Year
- BYSI 2017
- ICCM N/A
- Fundamental
- Price
- BYSI $1.63
- ICCM $1.06
- Analyst Decision
- BYSI
- ICCM Strong Buy
- Analyst Count
- BYSI 0
- ICCM 1
- Target Price
- BYSI N/A
- ICCM $2.50
- AVG Volume (30 Days)
- BYSI 32.8K
- ICCM 196.6K
- Earning Date
- BYSI 01-01-0001
- ICCM 05-27-2025
- Dividend Yield
- BYSI N/A
- ICCM N/A
- EPS Growth
- BYSI N/A
- ICCM N/A
- EPS
- BYSI N/A
- ICCM N/A
- Revenue
- BYSI N/A
- ICCM $3,291,000.00
- Revenue This Year
- BYSI N/A
- ICCM $97.02
- Revenue Next Year
- BYSI N/A
- ICCM $212.86
- P/E Ratio
- BYSI N/A
- ICCM N/A
- Revenue Growth
- BYSI N/A
- ICCM 1.92
- 52 Week Low
- BYSI $0.98
- ICCM $0.48
- 52 Week High
- BYSI $3.63
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- BYSI 54.68
- ICCM 37.29
- Support Level
- BYSI $1.64
- ICCM $1.00
- Resistance Level
- BYSI $2.14
- ICCM $1.10
- Average True Range (ATR)
- BYSI 0.17
- ICCM 0.08
- MACD
- BYSI 0.03
- ICCM -0.01
- Stochastic Oscillator
- BYSI 50.60
- ICCM 8.82
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.